Adragos Pharma acquires Baccinex

Munich, Germany headquartered contract development and manufacturing organization (CDMO) Adragos Pharma has acquired Baccinex, a Swiss-based expert in aseptic fill-finish manufacturing.

This acquisition – financial terms of which were not disclosed - significantly enhances Adragos’ sterile manufacturing capabilities and marks a pivotal step in the expansion of its global network, the company noted.

Baccinex, based in Courroux, Jura, Switzerland, brings over 20 years of experience in sterile fill-finish processes for both liquid and lyophilized vials. Operating from its EU-GMP and US FDA-certified facility, Baccinex specializes in clinical trial supplies and small-to-medium scale commercial production, offering world-class quality and reliability to its pharmaceutical clients.